# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5314361 | Nemorubicin | inhibition | = | 1.7 | % | ALA4808150 | % | Homo sapiens | |||
2. | ALA5314361 | Nemorubicin | inhibition | = | 43.21 | % | ALA4808149 | % | Homo sapiens | |||
3. | ALA5314361 | Nemorubicin | IC50 | = | 0.08 | uM | ALA4732607 | 7.10 | nM | Homo sapiens | ||
4. | ALA5314361 | Nemorubicin | Inhibition | = | 78.9 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | ALA5314361 | Nemorubicin | inhibition | = | 0.58 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | ALA5314361 | Nemorubicin | inhibition | = | 0.58 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | ALA5314361 | Nemorubicin | Inhibition | = | 13.674 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | ALA5314361 | Nemorubicin | Time | = | 5 | s | ALA1068002 | hr |